Clinical Trial Update: Non-Interventional Study of NovoSeven® Used in Patients With Haemophilia A and B With Inhibitors Under Normal Clinical Practice

View source ↗

Summary

This is an update on a non-interventional study evaluating NovoSeven in patients with Haemophilia A or B with inhibitors in routine clinical practice; the study…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Haemophilia with Inhibitors

Drugs mentioned

• NovoSeven (recombinant coagulation factor VIIa)

Snippet

Sponsor: Novo Nordisk A/S | Conditions: Congenital Bleeding Disorder, Haemophilia A With Inhibitors | Status: COMPLETED